COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Neurodegeneration Initiatives

You are viewing archived Blueprint content that is no longer current but is available for reference and record keeping purposes.

Biomarkers for Neurodegeneration
Closed December 9, 2006 - Seventeen awards made in FY07.

  • Unless neurodegenerative diseases can be diagnosed and treated at an early stage, irreversible cellular damage may occur.
  • This initiative supports the development of biomarkers that can be used for risk assessment, diagnosis, and post-diagnosis monitoring of disease.

Therapeutics Delivery for Neurodegenerative Diseases
Closed December 9, 2006 - Eleven awards made in FY07.

  • Despite promising strategies for treating neurodegenerative disease - e.g., engineered proteins, antibody-based "vaccines," and RNA interference - delivery of these agents to the nervous system remains a challenge.
  • This initiative supports the development of delivery tools, including new viral vectors and standardized cell lines.

Ruth L. Kirschstein NRSAs for Individual Postdoctoral Fellowships in Neurodegeneration Research
Closed December 9, 2006 - Three awards made in FY07.

  • Provides interdisciplinary training in neurodegeneration research at the postdoctoral level.

Short-Term Interdisciplinary Career Enhancement Awards for Neurodegeneration Research
Closed December 9, 2006 - Three awards made in FY07.

  • Enables established investigators to acquire interdisciplinary perspectives and skills in neurodegeneration research through short-term mentorship and training, typically during an academic sabbatical.